nodes	percent_of_prediction	percent_of_DWPC	metapath
Epoprostenol—PTGIR—pulmonary artery—sarcoma	0.0637	0.222	CbGeAlD
Epoprostenol—PTGIS—endothelium—sarcoma	0.0347	0.121	CbGeAlD
Epoprostenol—PTGIR—endothelium—sarcoma	0.02	0.0694	CbGeAlD
Epoprostenol—PTGIS—myometrium—sarcoma	0.0199	0.0691	CbGeAlD
Epoprostenol—PTGIS—connective tissue—sarcoma	0.0164	0.0571	CbGeAlD
Epoprostenol—P2RY12—hematopoietic system—sarcoma	0.0154	0.0534	CbGeAlD
Epoprostenol—PTGIS—smooth muscle tissue—sarcoma	0.015	0.0523	CbGeAlD
Epoprostenol—PTGIS—uterus—sarcoma	0.0129	0.0448	CbGeAlD
Epoprostenol—PTGIS—tendon—sarcoma	0.0113	0.0393	CbGeAlD
Epoprostenol—PTGIR—hematopoietic system—sarcoma	0.0098	0.0341	CbGeAlD
Epoprostenol—PTGIR—connective tissue—sarcoma	0.00944	0.0328	CbGeAlD
Epoprostenol—PTGIS—testis—sarcoma	0.00935	0.0325	CbGeAlD
Epoprostenol—PTGIS—liver—sarcoma	0.00884	0.0307	CbGeAlD
Epoprostenol—PTGIR—smooth muscle tissue—sarcoma	0.00863	0.03	CbGeAlD
Epoprostenol—PTGIS—lymph node—sarcoma	0.00678	0.0236	CbGeAlD
Epoprostenol—CYP2C9—mammary gland—sarcoma	0.00575	0.02	CbGeAlD
Epoprostenol—PTGIR—testis—sarcoma	0.00537	0.0187	CbGeAlD
Epoprostenol—PTGIR—liver—sarcoma	0.00508	0.0177	CbGeAlD
Epoprostenol—PTGIR—lymph node—sarcoma	0.00389	0.0135	CbGeAlD
Epoprostenol—CYP2C9—hematopoietic system—sarcoma	0.0035	0.0122	CbGeAlD
Epoprostenol—CYP2C9—liver—sarcoma	0.00181	0.00631	CbGeAlD
Epoprostenol—Paraesthesia—Mitoxantrone—sarcoma	0.00121	0.00169	CcSEcCtD
Epoprostenol—Loss of consciousness—Etoposide—sarcoma	0.0012	0.00169	CcSEcCtD
Epoprostenol—Decreased appetite—Vincristine—sarcoma	0.0012	0.00168	CcSEcCtD
Epoprostenol—Dyspnoea—Mitoxantrone—sarcoma	0.0012	0.00168	CcSEcCtD
Epoprostenol—Cough—Etoposide—sarcoma	0.0012	0.00168	CcSEcCtD
Epoprostenol—Somnolence—Mitoxantrone—sarcoma	0.00119	0.00168	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Vincristine—sarcoma	0.00119	0.00167	CcSEcCtD
Epoprostenol—Fatigue—Vincristine—sarcoma	0.00119	0.00167	CcSEcCtD
Epoprostenol—Dyspepsia—Mitoxantrone—sarcoma	0.00118	0.00166	CcSEcCtD
Epoprostenol—Pain—Vincristine—sarcoma	0.00118	0.00166	CcSEcCtD
Epoprostenol—Constipation—Vincristine—sarcoma	0.00118	0.00166	CcSEcCtD
Epoprostenol—Decreased appetite—Mitoxantrone—sarcoma	0.00117	0.00164	CcSEcCtD
Epoprostenol—Chest pain—Etoposide—sarcoma	0.00117	0.00164	CcSEcCtD
Epoprostenol—Orthostatic hypotension—Epirubicin—sarcoma	0.00116	0.00163	CcSEcCtD
Epoprostenol—Fatigue—Mitoxantrone—sarcoma	0.00116	0.00163	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00116	0.00163	CcSEcCtD
Epoprostenol—Pain—Mitoxantrone—sarcoma	0.00115	0.00161	CcSEcCtD
Epoprostenol—Constipation—Mitoxantrone—sarcoma	0.00115	0.00161	CcSEcCtD
Epoprostenol—Hypersensitivity—Thiotepa—sarcoma	0.00115	0.00161	CcSEcCtD
Epoprostenol—Hypersensitivity—Dactinomycin—sarcoma	0.00114	0.0016	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Vincristine—sarcoma	0.00113	0.00158	CcSEcCtD
Epoprostenol—Gastritis—Epirubicin—sarcoma	0.00113	0.00158	CcSEcCtD
Epoprostenol—Confusional state—Etoposide—sarcoma	0.00113	0.00158	CcSEcCtD
Epoprostenol—Anaphylactic shock—Etoposide—sarcoma	0.00112	0.00157	CcSEcCtD
Epoprostenol—Asthenia—Thiotepa—sarcoma	0.00112	0.00157	CcSEcCtD
Epoprostenol—Infection—Etoposide—sarcoma	0.00111	0.00156	CcSEcCtD
Epoprostenol—Abdominal distension—Epirubicin—sarcoma	0.00111	0.00156	CcSEcCtD
Epoprostenol—Asthenia—Dactinomycin—sarcoma	0.00111	0.00156	CcSEcCtD
Epoprostenol—Pruritus—Thiotepa—sarcoma	0.0011	0.00155	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Mitoxantrone—sarcoma	0.0011	0.00154	CcSEcCtD
Epoprostenol—Thrombocytopenia—Etoposide—sarcoma	0.00109	0.00154	CcSEcCtD
Epoprostenol—Tachycardia—Etoposide—sarcoma	0.00109	0.00153	CcSEcCtD
Epoprostenol—Body temperature increased—Vincristine—sarcoma	0.00109	0.00153	CcSEcCtD
Epoprostenol—Abdominal pain—Vincristine—sarcoma	0.00109	0.00153	CcSEcCtD
Epoprostenol—Skin disorder—Etoposide—sarcoma	0.00109	0.00152	CcSEcCtD
Epoprostenol—Hyperhidrosis—Etoposide—sarcoma	0.00108	0.00152	CcSEcCtD
Epoprostenol—Orthostatic hypotension—Doxorubicin—sarcoma	0.00108	0.00151	CcSEcCtD
Epoprostenol—Urticaria—Mitoxantrone—sarcoma	0.00107	0.0015	CcSEcCtD
Epoprostenol—Anorexia—Etoposide—sarcoma	0.00107	0.0015	CcSEcCtD
Epoprostenol—Diarrhoea—Thiotepa—sarcoma	0.00106	0.00149	CcSEcCtD
Epoprostenol—Body temperature increased—Mitoxantrone—sarcoma	0.00106	0.00149	CcSEcCtD
Epoprostenol—Abdominal pain—Mitoxantrone—sarcoma	0.00106	0.00149	CcSEcCtD
Epoprostenol—Diarrhoea—Dactinomycin—sarcoma	0.00106	0.00148	CcSEcCtD
Epoprostenol—Pancytopenia—Epirubicin—sarcoma	0.00105	0.00147	CcSEcCtD
Epoprostenol—Hypotension—Etoposide—sarcoma	0.00104	0.00147	CcSEcCtD
Epoprostenol—Gastritis—Doxorubicin—sarcoma	0.00104	0.00147	CcSEcCtD
Epoprostenol—Dizziness—Thiotepa—sarcoma	0.00103	0.00144	CcSEcCtD
Epoprostenol—Abdominal distension—Doxorubicin—sarcoma	0.00103	0.00144	CcSEcCtD
Epoprostenol—Hypersensitivity—Vincristine—sarcoma	0.00102	0.00143	CcSEcCtD
Epoprostenol—Paraesthesia—Etoposide—sarcoma	0.001	0.00141	CcSEcCtD
Epoprostenol—Weight decreased—Epirubicin—sarcoma	0.000997	0.0014	CcSEcCtD
Epoprostenol—Dyspnoea—Etoposide—sarcoma	0.000997	0.0014	CcSEcCtD
Epoprostenol—Somnolence—Etoposide—sarcoma	0.000994	0.0014	CcSEcCtD
Epoprostenol—Hypersensitivity—Mitoxantrone—sarcoma	0.00099	0.00139	CcSEcCtD
Epoprostenol—Asthenia—Vincristine—sarcoma	0.00099	0.00139	CcSEcCtD
Epoprostenol—Vomiting—Thiotepa—sarcoma	0.00099	0.00139	CcSEcCtD
Epoprostenol—Pneumonia—Epirubicin—sarcoma	0.000988	0.00139	CcSEcCtD
Epoprostenol—Infestation—Epirubicin—sarcoma	0.000983	0.00138	CcSEcCtD
Epoprostenol—Infestation NOS—Epirubicin—sarcoma	0.000983	0.00138	CcSEcCtD
Epoprostenol—Vomiting—Dactinomycin—sarcoma	0.000982	0.00138	CcSEcCtD
Epoprostenol—Rash—Thiotepa—sarcoma	0.000981	0.00138	CcSEcCtD
Epoprostenol—Dermatitis—Thiotepa—sarcoma	0.00098	0.00138	CcSEcCtD
Epoprostenol—Headache—Thiotepa—sarcoma	0.000975	0.00137	CcSEcCtD
Epoprostenol—Rash—Dactinomycin—sarcoma	0.000974	0.00137	CcSEcCtD
Epoprostenol—Decreased appetite—Etoposide—sarcoma	0.000972	0.00136	CcSEcCtD
Epoprostenol—Pancytopenia—Doxorubicin—sarcoma	0.000968	0.00136	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Etoposide—sarcoma	0.000965	0.00135	CcSEcCtD
Epoprostenol—Asthenia—Mitoxantrone—sarcoma	0.000964	0.00135	CcSEcCtD
Epoprostenol—Fatigue—Etoposide—sarcoma	0.000964	0.00135	CcSEcCtD
Epoprostenol—Pain—Etoposide—sarcoma	0.000956	0.00134	CcSEcCtD
Epoprostenol—Constipation—Etoposide—sarcoma	0.000956	0.00134	CcSEcCtD
Epoprostenol—Urinary tract infection—Epirubicin—sarcoma	0.000955	0.00134	CcSEcCtD
Epoprostenol—Diarrhoea—Vincristine—sarcoma	0.000944	0.00133	CcSEcCtD
Epoprostenol—Sweating—Epirubicin—sarcoma	0.000942	0.00132	CcSEcCtD
Epoprostenol—Haematuria—Epirubicin—sarcoma	0.000937	0.00132	CcSEcCtD
Epoprostenol—Epistaxis—Epirubicin—sarcoma	0.000927	0.0013	CcSEcCtD
Epoprostenol—Nausea—Thiotepa—sarcoma	0.000924	0.0013	CcSEcCtD
Epoprostenol—Weight decreased—Doxorubicin—sarcoma	0.000923	0.00129	CcSEcCtD
Epoprostenol—Sinusitis—Epirubicin—sarcoma	0.000922	0.00129	CcSEcCtD
Epoprostenol—Diarrhoea—Mitoxantrone—sarcoma	0.00092	0.00129	CcSEcCtD
Epoprostenol—Nausea—Dactinomycin—sarcoma	0.000918	0.00129	CcSEcCtD
Epoprostenol—Pneumonia—Doxorubicin—sarcoma	0.000914	0.00128	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Etoposide—sarcoma	0.000914	0.00128	CcSEcCtD
Epoprostenol—Dizziness—Vincristine—sarcoma	0.000913	0.00128	CcSEcCtD
Epoprostenol—Infestation—Doxorubicin—sarcoma	0.000909	0.00128	CcSEcCtD
Epoprostenol—Infestation NOS—Doxorubicin—sarcoma	0.000909	0.00128	CcSEcCtD
Epoprostenol—Bradycardia—Epirubicin—sarcoma	0.000898	0.00126	CcSEcCtD
Epoprostenol—Urticaria—Etoposide—sarcoma	0.000888	0.00125	CcSEcCtD
Epoprostenol—Haemoglobin—Epirubicin—sarcoma	0.000887	0.00124	CcSEcCtD
Epoprostenol—Rhinitis—Epirubicin—sarcoma	0.000884	0.00124	CcSEcCtD
Epoprostenol—Abdominal pain—Etoposide—sarcoma	0.000884	0.00124	CcSEcCtD
Epoprostenol—Body temperature increased—Etoposide—sarcoma	0.000884	0.00124	CcSEcCtD
Epoprostenol—Urinary tract infection—Doxorubicin—sarcoma	0.000884	0.00124	CcSEcCtD
Epoprostenol—Haemorrhage—Epirubicin—sarcoma	0.000882	0.00124	CcSEcCtD
Epoprostenol—Hypoaesthesia—Epirubicin—sarcoma	0.000878	0.00123	CcSEcCtD
Epoprostenol—Vomiting—Vincristine—sarcoma	0.000877	0.00123	CcSEcCtD
Epoprostenol—Pharyngitis—Epirubicin—sarcoma	0.000875	0.00123	CcSEcCtD
Epoprostenol—Sweating—Doxorubicin—sarcoma	0.000872	0.00122	CcSEcCtD
Epoprostenol—Rash—Vincristine—sarcoma	0.00087	0.00122	CcSEcCtD
Epoprostenol—Dermatitis—Vincristine—sarcoma	0.000869	0.00122	CcSEcCtD
Epoprostenol—Oedema peripheral—Epirubicin—sarcoma	0.000869	0.00122	CcSEcCtD
Epoprostenol—Haematuria—Doxorubicin—sarcoma	0.000867	0.00122	CcSEcCtD
Epoprostenol—Connective tissue disorder—Epirubicin—sarcoma	0.000867	0.00122	CcSEcCtD
Epoprostenol—Headache—Vincristine—sarcoma	0.000865	0.00121	CcSEcCtD
Epoprostenol—Epistaxis—Doxorubicin—sarcoma	0.000858	0.0012	CcSEcCtD
Epoprostenol—Vomiting—Mitoxantrone—sarcoma	0.000855	0.0012	CcSEcCtD
Epoprostenol—Sinusitis—Doxorubicin—sarcoma	0.000853	0.0012	CcSEcCtD
Epoprostenol—Rash—Mitoxantrone—sarcoma	0.000847	0.00119	CcSEcCtD
Epoprostenol—Dermatitis—Mitoxantrone—sarcoma	0.000847	0.00119	CcSEcCtD
Epoprostenol—Headache—Mitoxantrone—sarcoma	0.000842	0.00118	CcSEcCtD
Epoprostenol—Bradycardia—Doxorubicin—sarcoma	0.000831	0.00117	CcSEcCtD
Epoprostenol—Hypersensitivity—Etoposide—sarcoma	0.000824	0.00116	CcSEcCtD
Epoprostenol—Haemoglobin—Doxorubicin—sarcoma	0.00082	0.00115	CcSEcCtD
Epoprostenol—Nausea—Vincristine—sarcoma	0.00082	0.00115	CcSEcCtD
Epoprostenol—Cardiac disorder—Epirubicin—sarcoma	0.000819	0.00115	CcSEcCtD
Epoprostenol—Flushing—Epirubicin—sarcoma	0.000819	0.00115	CcSEcCtD
Epoprostenol—Rhinitis—Doxorubicin—sarcoma	0.000818	0.00115	CcSEcCtD
Epoprostenol—Haemorrhage—Doxorubicin—sarcoma	0.000816	0.00115	CcSEcCtD
Epoprostenol—Hypoaesthesia—Doxorubicin—sarcoma	0.000812	0.00114	CcSEcCtD
Epoprostenol—Pharyngitis—Doxorubicin—sarcoma	0.00081	0.00114	CcSEcCtD
Epoprostenol—Oedema peripheral—Doxorubicin—sarcoma	0.000804	0.00113	CcSEcCtD
Epoprostenol—Asthenia—Etoposide—sarcoma	0.000802	0.00113	CcSEcCtD
Epoprostenol—Connective tissue disorder—Doxorubicin—sarcoma	0.000802	0.00113	CcSEcCtD
Epoprostenol—Angiopathy—Epirubicin—sarcoma	0.0008	0.00112	CcSEcCtD
Epoprostenol—Nausea—Mitoxantrone—sarcoma	0.000798	0.00112	CcSEcCtD
Epoprostenol—Mediastinal disorder—Epirubicin—sarcoma	0.000795	0.00112	CcSEcCtD
Epoprostenol—Chills—Epirubicin—sarcoma	0.000791	0.00111	CcSEcCtD
Epoprostenol—Pruritus—Etoposide—sarcoma	0.000791	0.00111	CcSEcCtD
Epoprostenol—Mental disorder—Epirubicin—sarcoma	0.000773	0.00108	CcSEcCtD
Epoprostenol—Diarrhoea—Etoposide—sarcoma	0.000765	0.00107	CcSEcCtD
Epoprostenol—Flushing—Doxorubicin—sarcoma	0.000757	0.00106	CcSEcCtD
Epoprostenol—Cardiac disorder—Doxorubicin—sarcoma	0.000757	0.00106	CcSEcCtD
Epoprostenol—Flatulence—Epirubicin—sarcoma	0.000757	0.00106	CcSEcCtD
Epoprostenol—Tension—Epirubicin—sarcoma	0.000754	0.00106	CcSEcCtD
Epoprostenol—Nervousness—Epirubicin—sarcoma	0.000746	0.00105	CcSEcCtD
Epoprostenol—Back pain—Epirubicin—sarcoma	0.000743	0.00104	CcSEcCtD
Epoprostenol—Angiopathy—Doxorubicin—sarcoma	0.00074	0.00104	CcSEcCtD
Epoprostenol—Dizziness—Etoposide—sarcoma	0.000739	0.00104	CcSEcCtD
Epoprostenol—Muscle spasms—Epirubicin—sarcoma	0.000738	0.00104	CcSEcCtD
Epoprostenol—Mediastinal disorder—Doxorubicin—sarcoma	0.000736	0.00103	CcSEcCtD
Epoprostenol—Chills—Doxorubicin—sarcoma	0.000732	0.00103	CcSEcCtD
Epoprostenol—Mental disorder—Doxorubicin—sarcoma	0.000715	0.001	CcSEcCtD
Epoprostenol—Vomiting—Etoposide—sarcoma	0.000711	0.000998	CcSEcCtD
Epoprostenol—Anaemia—Epirubicin—sarcoma	0.00071	0.000996	CcSEcCtD
Epoprostenol—Agitation—Epirubicin—sarcoma	0.000706	0.00099	CcSEcCtD
Epoprostenol—Rash—Etoposide—sarcoma	0.000705	0.000989	CcSEcCtD
Epoprostenol—Dermatitis—Etoposide—sarcoma	0.000704	0.000989	CcSEcCtD
Epoprostenol—Headache—Etoposide—sarcoma	0.0007	0.000983	CcSEcCtD
Epoprostenol—Flatulence—Doxorubicin—sarcoma	0.0007	0.000983	CcSEcCtD
Epoprostenol—Tension—Doxorubicin—sarcoma	0.000697	0.000979	CcSEcCtD
Epoprostenol—Nervousness—Doxorubicin—sarcoma	0.00069	0.000969	CcSEcCtD
Epoprostenol—Syncope—Epirubicin—sarcoma	0.000689	0.000967	CcSEcCtD
Epoprostenol—Back pain—Doxorubicin—sarcoma	0.000687	0.000965	CcSEcCtD
Epoprostenol—Muscle spasms—Doxorubicin—sarcoma	0.000683	0.000959	CcSEcCtD
Epoprostenol—Palpitations—Epirubicin—sarcoma	0.000679	0.000952	CcSEcCtD
Epoprostenol—Loss of consciousness—Epirubicin—sarcoma	0.000675	0.000947	CcSEcCtD
Epoprostenol—Cough—Epirubicin—sarcoma	0.00067	0.000941	CcSEcCtD
Epoprostenol—Nausea—Etoposide—sarcoma	0.000664	0.000932	CcSEcCtD
Epoprostenol—Anaemia—Doxorubicin—sarcoma	0.000657	0.000922	CcSEcCtD
Epoprostenol—Chest pain—Epirubicin—sarcoma	0.000654	0.000918	CcSEcCtD
Epoprostenol—Arthralgia—Epirubicin—sarcoma	0.000654	0.000918	CcSEcCtD
Epoprostenol—Myalgia—Epirubicin—sarcoma	0.000654	0.000918	CcSEcCtD
Epoprostenol—Agitation—Doxorubicin—sarcoma	0.000653	0.000916	CcSEcCtD
Epoprostenol—Anxiety—Epirubicin—sarcoma	0.000651	0.000914	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000649	0.000911	CcSEcCtD
Epoprostenol—Dry mouth—Epirubicin—sarcoma	0.000639	0.000897	CcSEcCtD
Epoprostenol—Syncope—Doxorubicin—sarcoma	0.000637	0.000894	CcSEcCtD
Epoprostenol—Confusional state—Epirubicin—sarcoma	0.000632	0.000887	CcSEcCtD
Epoprostenol—Palpitations—Doxorubicin—sarcoma	0.000628	0.000881	CcSEcCtD
Epoprostenol—Oedema—Epirubicin—sarcoma	0.000627	0.00088	CcSEcCtD
Epoprostenol—Anaphylactic shock—Epirubicin—sarcoma	0.000627	0.00088	CcSEcCtD
Epoprostenol—Loss of consciousness—Doxorubicin—sarcoma	0.000624	0.000877	CcSEcCtD
Epoprostenol—Infection—Epirubicin—sarcoma	0.000623	0.000874	CcSEcCtD
Epoprostenol—Cough—Doxorubicin—sarcoma	0.00062	0.00087	CcSEcCtD
Epoprostenol—Shock—Epirubicin—sarcoma	0.000617	0.000865	CcSEcCtD
Epoprostenol—Nervous system disorder—Epirubicin—sarcoma	0.000615	0.000863	CcSEcCtD
Epoprostenol—Thrombocytopenia—Epirubicin—sarcoma	0.000614	0.000861	CcSEcCtD
Epoprostenol—Tachycardia—Epirubicin—sarcoma	0.000612	0.000859	CcSEcCtD
Epoprostenol—Skin disorder—Epirubicin—sarcoma	0.000609	0.000854	CcSEcCtD
Epoprostenol—Hyperhidrosis—Epirubicin—sarcoma	0.000606	0.00085	CcSEcCtD
Epoprostenol—Arthralgia—Doxorubicin—sarcoma	0.000605	0.000849	CcSEcCtD
Epoprostenol—Chest pain—Doxorubicin—sarcoma	0.000605	0.000849	CcSEcCtD
Epoprostenol—Myalgia—Doxorubicin—sarcoma	0.000605	0.000849	CcSEcCtD
Epoprostenol—Anxiety—Doxorubicin—sarcoma	0.000603	0.000846	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000601	0.000843	CcSEcCtD
Epoprostenol—Anorexia—Epirubicin—sarcoma	0.000597	0.000838	CcSEcCtD
Epoprostenol—Dry mouth—Doxorubicin—sarcoma	0.000592	0.00083	CcSEcCtD
Epoprostenol—Hypotension—Epirubicin—sarcoma	0.000586	0.000822	CcSEcCtD
Epoprostenol—Confusional state—Doxorubicin—sarcoma	0.000585	0.000821	CcSEcCtD
Epoprostenol—Anaphylactic shock—Doxorubicin—sarcoma	0.00058	0.000814	CcSEcCtD
Epoprostenol—Oedema—Doxorubicin—sarcoma	0.00058	0.000814	CcSEcCtD
Epoprostenol—Infection—Doxorubicin—sarcoma	0.000576	0.000809	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000571	0.000801	CcSEcCtD
Epoprostenol—Shock—Doxorubicin—sarcoma	0.00057	0.000801	CcSEcCtD
Epoprostenol—Nervous system disorder—Doxorubicin—sarcoma	0.000569	0.000798	CcSEcCtD
Epoprostenol—Thrombocytopenia—Doxorubicin—sarcoma	0.000568	0.000797	CcSEcCtD
Epoprostenol—Insomnia—Epirubicin—sarcoma	0.000567	0.000796	CcSEcCtD
Epoprostenol—Tachycardia—Doxorubicin—sarcoma	0.000566	0.000794	CcSEcCtD
Epoprostenol—Skin disorder—Doxorubicin—sarcoma	0.000563	0.000791	CcSEcCtD
Epoprostenol—Paraesthesia—Epirubicin—sarcoma	0.000563	0.00079	CcSEcCtD
Epoprostenol—Hyperhidrosis—Doxorubicin—sarcoma	0.000561	0.000787	CcSEcCtD
Epoprostenol—Dyspnoea—Epirubicin—sarcoma	0.000559	0.000784	CcSEcCtD
Epoprostenol—Somnolence—Epirubicin—sarcoma	0.000557	0.000782	CcSEcCtD
Epoprostenol—Anorexia—Doxorubicin—sarcoma	0.000553	0.000776	CcSEcCtD
Epoprostenol—Dyspepsia—Epirubicin—sarcoma	0.000552	0.000774	CcSEcCtD
Epoprostenol—Decreased appetite—Epirubicin—sarcoma	0.000545	0.000765	CcSEcCtD
Epoprostenol—Hypotension—Doxorubicin—sarcoma	0.000542	0.000761	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Epirubicin—sarcoma	0.000541	0.000759	CcSEcCtD
Epoprostenol—Fatigue—Epirubicin—sarcoma	0.00054	0.000758	CcSEcCtD
Epoprostenol—Constipation—Epirubicin—sarcoma	0.000536	0.000752	CcSEcCtD
Epoprostenol—Pain—Epirubicin—sarcoma	0.000536	0.000752	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000528	0.000742	CcSEcCtD
Epoprostenol—Insomnia—Doxorubicin—sarcoma	0.000524	0.000736	CcSEcCtD
Epoprostenol—Paraesthesia—Doxorubicin—sarcoma	0.000521	0.000731	CcSEcCtD
Epoprostenol—Dyspnoea—Doxorubicin—sarcoma	0.000517	0.000726	CcSEcCtD
Epoprostenol—Somnolence—Doxorubicin—sarcoma	0.000515	0.000724	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Epirubicin—sarcoma	0.000512	0.000719	CcSEcCtD
Epoprostenol—Dyspepsia—Doxorubicin—sarcoma	0.00051	0.000716	CcSEcCtD
Epoprostenol—Decreased appetite—Doxorubicin—sarcoma	0.000504	0.000708	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000501	0.000703	CcSEcCtD
Epoprostenol—Fatigue—Doxorubicin—sarcoma	0.0005	0.000702	CcSEcCtD
Epoprostenol—Urticaria—Epirubicin—sarcoma	0.000498	0.000699	CcSEcCtD
Epoprostenol—Constipation—Doxorubicin—sarcoma	0.000496	0.000696	CcSEcCtD
Epoprostenol—Pain—Doxorubicin—sarcoma	0.000496	0.000696	CcSEcCtD
Epoprostenol—Abdominal pain—Epirubicin—sarcoma	0.000495	0.000695	CcSEcCtD
Epoprostenol—Body temperature increased—Epirubicin—sarcoma	0.000495	0.000695	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Doxorubicin—sarcoma	0.000474	0.000666	CcSEcCtD
Epoprostenol—Hypersensitivity—Epirubicin—sarcoma	0.000462	0.000648	CcSEcCtD
Epoprostenol—Urticaria—Doxorubicin—sarcoma	0.000461	0.000647	CcSEcCtD
Epoprostenol—Body temperature increased—Doxorubicin—sarcoma	0.000458	0.000643	CcSEcCtD
Epoprostenol—Abdominal pain—Doxorubicin—sarcoma	0.000458	0.000643	CcSEcCtD
Epoprostenol—Asthenia—Epirubicin—sarcoma	0.00045	0.000631	CcSEcCtD
Epoprostenol—Pruritus—Epirubicin—sarcoma	0.000443	0.000622	CcSEcCtD
Epoprostenol—Diarrhoea—Epirubicin—sarcoma	0.000429	0.000602	CcSEcCtD
Epoprostenol—Hypersensitivity—Doxorubicin—sarcoma	0.000427	0.0006	CcSEcCtD
Epoprostenol—Asthenia—Doxorubicin—sarcoma	0.000416	0.000584	CcSEcCtD
Epoprostenol—Dizziness—Epirubicin—sarcoma	0.000414	0.000582	CcSEcCtD
Epoprostenol—Pruritus—Doxorubicin—sarcoma	0.00041	0.000576	CcSEcCtD
Epoprostenol—Vomiting—Epirubicin—sarcoma	0.000398	0.000559	CcSEcCtD
Epoprostenol—Diarrhoea—Doxorubicin—sarcoma	0.000397	0.000557	CcSEcCtD
Epoprostenol—Rash—Epirubicin—sarcoma	0.000395	0.000555	CcSEcCtD
Epoprostenol—Dermatitis—Epirubicin—sarcoma	0.000395	0.000554	CcSEcCtD
Epoprostenol—Headache—Epirubicin—sarcoma	0.000393	0.000551	CcSEcCtD
Epoprostenol—Dizziness—Doxorubicin—sarcoma	0.000383	0.000538	CcSEcCtD
Epoprostenol—Nausea—Epirubicin—sarcoma	0.000372	0.000522	CcSEcCtD
Epoprostenol—Vomiting—Doxorubicin—sarcoma	0.000369	0.000517	CcSEcCtD
Epoprostenol—Rash—Doxorubicin—sarcoma	0.000366	0.000513	CcSEcCtD
Epoprostenol—Dermatitis—Doxorubicin—sarcoma	0.000365	0.000513	CcSEcCtD
Epoprostenol—Headache—Doxorubicin—sarcoma	0.000363	0.00051	CcSEcCtD
Epoprostenol—Nausea—Doxorubicin—sarcoma	0.000344	0.000483	CcSEcCtD
